{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":31,"n_cols":5,"rows_kept":31,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[13,2,13,3],[14,2,14,3],[17,2,17,3],[19,2,19,3],[19,4,19,5],[20,2,20,3],[20,4,20,5],[21,2,21,3],[21,4,21,5],[22,2,22,3],[24,2,24,3],[25,2,25,3],[27,2,27,3],[28,2,28,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910454427903321"]
[null,null,"Author",null,"Wender Paul H"]
[null,null,"Title",null,"ADHD [[electronic resource] ] : Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults"]
[null,null,"Publication",null,"Oxford, : Oxford University Press, USA, 2001"]
[null,null,"ISBN",null,"0-19-028325-4"]
[{"$nulls":4},"1-281-34674-8"]
[{"$nulls":4},"0-19-802733-8"]
[null,null,"Physical description",null,"1 online resource (288 p.)"]
[null,null,"Dewey",null,"616.8589"]
[null,null,"Subjects",null,"Attention-deficit hyperactivity disorder"]
[{"$nulls":4},"Attention-deficit-disordered adults"]
[{"$nulls":4},"Attention-deficit-disordered children"]
[{"$nulls":4},"Electronic books."]
[null,null,"Language",null,"English"]
[null,null,"Format",null,"Language material"]
[null,null,null,"Bibliographic level","Monograph"]
[null,null,null,"General notes","Description based upon print version of record."]
[null,null,"Formatted content note",null,"Contents; Preface; 1. Introduction; 2. The Characteristics of Children with Attention-Deficit Hyperactivity Disorder; 3. The Causes of Attention-Deficit Hyperactivity Disorder; 4. The Development of the Child with Attention-Deficit Hyperactivity Disorder; 5. Treatment of the Child with Attention-Deficit Hyperactivity Disorder; 6. Attention-Deficit Hyperactivity Disorder in Adults; 7. Finding Help; APPENDIX: Diagnostic Criteria: Diagnosis of ADHD in Childhood and Adulthood and Related Disorders; Index"]
[null,null,null,"Summary, etc","Paul Wender began his career treating children with ADHD 37 years ago and has treated adults with the disorder for almost 30 years. His exhaustive research and insight gained from clinical practice led to the first book about ADHD in children (Minimal Brain Dysfunction in Children, 1971). Continuing research revealed that in many instances ADHD persisted into adult life, and that adult ADHD included symptoms that were not present in childhood. These findings resulted in his 1995 book Attention Deficit Hyperactivity Disorder in Adults. He also authored the first book for the parents of children"]
[null,"2.","Record Nr.",null,"UNINA9910409834903321"]
[null,null,"Author",null,"Juhnke Christin"]
[null,null,"Title",null,"Adaptive Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen : Die Abwägung von Patientennutzen, Evidenz und Zugang / / Christin Juhnke, Axel C. Mühlbacher"]
[null,null,"Publication",null,"Berlin, : MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, 2016"]
[{"$nulls":4},"[s.l.] : , : MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, , 2016"]
[null,null,"Physical description",null,"1 online resource (1 p.)"]
[null,null,"Subjects",null,"Medical / Administration"]
[{"$nulls":4},"Medicine"]
[null,null,"Language",null,"German"]
[null,null,"Format",null,"Language material"]
[null,null,null,"Bibliographic level","Monograph"]
[null,null,null,"Summary, etc","Das GKV-VSG führte erstmalig die Nutzenbewertung von Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen und invasivem Charakter ein. Zukünftig wird die Entscheidung über die Erstattungsfähigkeit von der Dokumentation von Nutzen und Schaden abhängig sein. Grundsätzlich kann die Nutzenbewertung in drei Phasen unterteilt werden: Messen von kausalen Effekten einer Intervention, Bewertung der gemessenen Effekte und Entscheidung über die Erstattungsfähigkeit eines aggregierten Gesamtnutzens. Um den Anforderungen zu begegnen, stellen adaptive Studiendesigns, die multikriterielle Entscheidungsanalyse und die adaptive Nutzenbewertung ein zukunftsfähiges Konzept für einen schnellen Zugang von Patienten zu innovativen Behandlungsmethoden bei hoher Qualität und Sicherheit dar."]